RXRX: Recursion Pharmaceuticals, Inc.
Performance
RXRX -17.64%
Watchlist
Select an item
Summary
RXRX at a glance
RXRX returned -17.64% over the past year and -27.61% a year over five years. Its worst drop in that year was -42.74%, smaller than 33% of stocks on Redstone, and its Sharpe ratio of 0.06 beats 29% of stocks on Redstone. It pays no dividends.
Current Drawdown
-23.29%
Rolling Volatility
103.48%
Actions
Metrics
Risk Indicators
Alpha-23.44%
Beta2.80x
Sharpe0.06
Sortino0.08
Omega1.01
Calmar-0.41
Martin0.15
Profile
About RXRX
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $2.4B
- Listed
- Apr 2021
- Employees
- 600
- Headquarters
- Salt Lake City, UT
- Website
- recursion.com
Comparisons